1h Free Analyst Time
The immunology market is forecasted to grow by USD 56.07 bn during 2022-2027, accelerating at a CAGR of 8.84% during the forecast period. The report on the immunology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing organ transplantation, growing cases of infectious diseases, and hurdles in the approval of biosimilars.
The immunology market is segmented as below:
By Type
- Immunosuppressants
- Immuno boosters
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the immunology market covers the following areas:
- Immunology market sizing
- Immunology market forecast
- Immunology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global immunology market: AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB SA.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is hurdles in approval of biosimilars.`
According to the report, one of the major drivers for this market is the growing organ transplantation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3SBio Inc.
- AbbVie Inc.
- Amgen Inc.
- Antares Pharma Inc.
- Astellas Pharma Inc.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Horizon Therapeutics Plc
- ImmuNext Inc.
- Incyte Corp.
- Johnson and Johnson Services Inc.
- Merck KGaA
- Mitsubishi Chemical Group Corp.
- Novartis AG
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
- GlaxoSmithKline Plc
